Physician profile
Peter D Simone
NPI 1144630468
$2,069.09
in general payments reported to CMS, 2019-2025
19 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $12.33 · 2021: $274 · 2022: $268 · 2023: $268 · 2024: $267 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $375.84 | 2022-2025 | |
| Alcon Vision LLC | $291.11 | 2020-2025 | Argos, Clareon |
| Abbvie INC. | $181.00 | 2022-2025 | Durysta |
| Kala Pharmaceuticals, INC. | $176.69 | 2019 | |
| Genentech USA, INC. | $146.91 | 2019-2025 | Vabysmo |
| Carl Zeiss Meditec USA, INC. | $131.73 | 2023 | Visumax |
| Omeros Corporation | $125.00 | 2019 | |
| Horizon Therapeutics Plc | $98.39 | 2019-2021 | |
| The Cameron-Ehlen Group, INC. | $98.12 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $84.98 | 2023-2025 | Miebo, Envista Mx60 Iol, Ic-8 Apthera Iol |
| Sight Sciences, INC. | $84.76 | 2021-2024 | Omni Surgical System |
| Optos, INC. | $65.47 | 2021-2022 | |
| Harrow Eye, LLC | $64.79 | 2025 | Iheezo, Vevye |
| Astellas Pharma US INC | $47.93 | 2024-2025 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $32.24 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $19.51 | 2021 | |
| Glaukos Corporation | $17.41 | 2021 | |
| Eyepoint US, INC. | $13.87 | 2021 | |
| Allergan, INC. | $13.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Simone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.